Thermo Fisher Scientific (TMO) Non Operating Interest Expenses (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Non Operating Interest Expenses for 15 consecutive years, with $401.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses fell 0.74% year-over-year to $401.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.5 billion (up 6.3% YoY), and the FY2025 full-year result was $1.4 billion, up 2.09% from the prior year.
• Non Operating Interest Expenses grew to $401.0 million in Q2 2026 per TMO's latest filing, from $354.0 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $404.0 million in Q2 2025 and bottomed at $136.0 million in Q2 2022.
• Historically, Non Operating Interest Expenses has averaged $314.7 million across 5 years, with a median of $350.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Non Operating Interest Expenses surged 120.59% in 2023, then slipped 18.72% in 2024.
• Over 5 years, Non Operating Interest Expenses stood at $269.0 million in 2022, then soared by 44.98% to $390.0 million in 2023, then retreated by 18.72% to $317.0 million in 2024, then climbed by 15.14% to $365.0 million in 2025, then climbed by 9.86% to $401.0 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $401.0 million, $354.0 million, and $365.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.